ctrl K

Price Alert

Ambrx Biopharma Inc. (AMAM)

NYSE: AMAM · Real-Time Price · USD

28.00

0.02 (0.07%)

At close: Mar 06, 2024, 10:00 PM

Ambrx Biopharma Revenue Breakdown

Period Ending	Dec 31, 2021
License Fees Revenue	3.53M
License Fees Revenue Growth	n/a
Reimbursements Revenue	1.85M
Reimbursements Revenue Growth	n/a
Research And Development Services Revenue	2.07M
Research And Development Services Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Selling, General, and Administrative Revenue	9.41M	5.9M	7.32M	6.27M	6.27M	4.82M	5.35M	4.65M	4.65M	4.49M	4.49M	1.91M	1.91M	1.88M	1.88M
Selling, General, and Administrative Revenue Growth	+59.49%	-19.39%	+16.67%	0.00%	+30.07%	-9.92%	+15.18%	0.00%	+3.56%	0.00%	+134.51%	0.00%	+1.59%	0.00%	n/a
Research and Development Revenue	16.27M	14.39M	9.75M	10.27M	10.27M	18.06M	14.7M	16.11M	16.11M	11.04M	11.04M	5.25M	5.25M	4.97M	4.97M
Research and Development Revenue Growth	+13.03%	+47.62%	-5.07%	0.00%	-43.14%	+22.84%	-8.72%	0.00%	+45.91%	0.00%	+110.36%	0.00%	+5.63%	0.00%	n/a